Lasso (lassoplatform.io), an end-to-end operating system for healthcare marketing and analytics, released the results of an HCP campaign with BioPharm Communications leveraging Lasso's Premium Endemic Publisher Marketplace for a leading brand of heart disease medication.
In May, Lasso launched their Publisher Suite and Endemic Marketplace to provide the ultimate end-to-end solution for the healthcare communications industry. Since then, the platform has delivered priority access to top publisher inventory from GoodRx, Haymarket Medical Network, The BMJ, GlobalRPH, Radiopaedia, and many more for their agency and brand partners.
Since BioPharm's offering involves creating individualized experiences for targeted HCPs from a clinical perspective, they knew they would benefit from expanding their programmatic reach to additional endemic placements for more preferred content consumption. Their typical channel mix includes email, print, paid social, and programmatic media, and for the campaign mentioned they were able to utilize Lasso's Endemic Marketplace to enhance their programmatic media placements. The overall goal with this channel expansion was to improve reach, media engagement, and real-world impact attributed to serving 3rd-party branded ads to targeted physicians who were traditionally not found on the open internet.